Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)
- Authors
- Yoo, C.; Kim, H-D.; Chon, H. J.; Sym, S. J.; Kim, M.; Kang, J. H.; Ryoo, B-Y.; Lee, C-K.; Hong, J.; Ryu, H.; Bae, W. K.; Kim, H.; Kim, H.; Kim, J. W.; Kim, T-Y.
- Issue Date
- Dec-2024
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.35, pp S1450 - S1450
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 35
- Start Page
- S1450
- End Page
- S1450
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.